Mark Worthington - 01 Jun 2021 Form 3 Insider Report for Athira Pharma, Inc. (ATHA)

Role
General Counsel
Signature
/s/ Glenna Mileson, Attorney in Fact for Mark Worthington
Issuer symbol
ATHA
Transactions as of
01 Jun 2021
Net transactions value
$0
Form type
3
Filing time
01 Jun 2021, 18:32:10 UTC
Next filing
05 Nov 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding ATHA Common Stock 8,315 01 Jun 2021 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding ATHA No securities are beneficially owned. 01 Jun 2021 Not Applicable 0 $0.000000 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Not applicable